Epidemiological trends and characteristics of Japanese encephalitis changed based on the vaccination program between 1960 and 2013 in Guangxi Zhuang Autonomous Region, southern China  by Yang, Yan et al.
International Journal of Infectious Diseases 45 (2016) 135–138Epidemiological trends and characteristics of Japanese encephalitis
changed based on the vaccination program between 1960 and 2013 in
Guangxi Zhuang Autonomous Region, southern China
Yan Yang a,1, Nengxiu Liang a,1, Yi Tan b, Zhichun Xie a,*
a Section of Epidemiology and Statistics, School of Public Health, Guangxi Medical University, 22 Shuangyong Road, Nanning 530021, Guangxi Zhuang
Autonomous Region, China
b Section of Acute Communicable Diseases Control and Prevention, Guangxi Zhuang Autonomous Region Centre for Diseases Control and Prevention, Guangxi
Zhuang Autonomous Region, China
A R T I C L E I N F O
Article history:
Received 20 October 2015
Received in revised form 27 February 2016
Accepted 3 March 2016
Corresponding Editor: Eskild Petersen,
Aarhus, Denmark.
Keywords:
Japanese encephalitis
Characteristics
Vaccination program
Guangxi
S U M M A R Y
Japanese encephalitis (JE) is one of the most severe kinds of viral encephalitis and is prevalent in Asia and
the Western Paciﬁc. In China, JE was ﬁrst reported in the 1940s and became the main cause of viral
encephalitis, including in the Guangxi Zhuang Autonomous Region. In 1951, JE was included in
the Chinese mandatory disease reporting system. In the pre-vaccine era of the 1960s and 1970s, the
incidence of JE continued to rise without any vaccine supply. Since JE vaccines became available in
the late 1970s (MBD) and 1989 (LAV-SA-14-14-2), and as JE vaccine became freely available to patients
beginning in 2008, the incidence of JE has declined signiﬁcantly. Despite these gains, outbreaks continue
to occur among children in rural and suburban areas. Strengthening vaccine delivery models and
improving swine vaccine production are important in order to sustain continuous declines in the
incidence of JE in Guangxi.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Japanese encephalitis (JE) is a serious threat to human lives and
is caused by the Japanese encephalitis virus (JEV), which belongs to
the Flaviviridae family. The ﬁrst major epidemic of JE occurred in
1924 in Japan.1 Since then, JE has been found increasingly in most
countries of Asia, especially in the south-east areas.2 Over three
billion individuals have been found in JE epidemic/endemic
countries.3 According to a report by the World Health Organiza-
tion, the number of cases worldwide in 2007 was 9487, including
4330 cases in China, 4017 cases in India, and 435 cases in Nepal.1
JEV generally affects young children (<15 years old) and elderly
people (>65 years old), who have a weak immune system and
hence are vulnerable.4 The fatality in JE cases ranges from 20% to
30%, with neurological and/or psychiatric sequelae observed in 30%
to 50% of survivors.15 JE was ﬁrst reported in the 1940s and became
the main cause of viral encephalitis in China.5 Guangxi, which is in
the south-east area of Asia, is a southern province of China. The* Corresponding author. Tel.: +86 771 5358847; fax: +86 771 5358847.
E-mail address: 357154887@qq.com (Z. Xie).
1 Yan Yang and Nengxiu Liang contributed equally to this work.
http://dx.doi.org/10.1016/j.ijid.2016.03.004
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).geographic distribution of Culex gelidus Theobald, which is the
vector of JEV and a mosquito native to Southeast Asia, has
increased during recent decades, covering the whole of Southeast
Asia, Australia, and several Paciﬁc Islands.6,7
2. Materials and methods
2.1. Data
The data for the period 1960 to 1998 were provided by the
Department of Epidemic Information, Centre for Disease Control
and Prevention of Guangxi Zhuang Autonomous Region. The data
for the period 1999 to 2013 were extracted from the National
Notiﬁable Disease Reporting System (NNDRS) of P. R. China.
Statistics on the population were obtained from the Guangxi
Statistical Almanac.
2.2. Methods
IBM SPSS Statistics for Windows, version 19.0 (IBM Corp.,
Armonk, NY, USA) was used for the data analysis. The administra-
tive divisions of the Province, as suggested by the Provincialciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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Figure 2. Case number of Japanese encephalitis by month, 1960–2013; Guangxi,
China.
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geographical variations in the incidence of JE. Guangxi Province
is divided into 14 regions.
3. Results
3.1. Epidemic situation and trends
Between 1960 and 2013, 65 520 cases were reported in
Guangxi, including 11 879 deaths. The average incidence rate of
JE over the 53 years was 3.39/100 000, the average mortality rate
was 0.61/100 000, and the case fatality rate was 18.13%. The peak
incidence (25.64/100 000) was reached in 1969. The lowest
incidence of 0.03/100 000 was found in 2013. The incidence of
JE in Guangxi increased continuously during the 1960s and 1970s,
with an average incidence rate of 9.24/100 000 (the lowest rate
was 1.69/100 000 and the highest was 21.82/100 000). The
incidence decreased by degrees starting in the 1980s. In addition,
the variability in the annual incidence rate ceased and regional
outbreaks became more sporadic (Table 1, Figure 1).
3.2. Epidemic characteristics
3.2.1. Seasonal distribution
All of the cases in the 53 years from 1960 to 2013 were
distributed across every month, with 95.83% of the cases
concentrated in ﬁve consecutive months of each year: May, June,
July, August, and September. July, accounting for 45.21% of the total
number of cases during the years 1950–2013, was the month with
the most serious epidemic (Figure 2).
3.2.2. Distribution of different geographic areas
All of the 14 cities in the province reported cases of JE in the
53 years from 1960 to 2013. Guigang City had the highest
incidence rate of 5.40/100 000, followed by the cities of
Fangchenggang, Beihai, Laibin, and Yulin with incidence rates ofTable 1
Number and rates of Japanese encephalitis cases by decade, 1960–2013; Guangxi,
China
Decade Number
of cases
Number of cases from
May to September
Proportion
1960– 21 583 20 611 95.50%
1970– 28 541 27 324 95.74%
1980– 7113 6861 96.46%
1990– 5814 5573 95.85%
2000– 2278 2236 98.16%
2010–2013 191 185 96.86%
Total 65 520 62 790 95.83%
Figure 1. Japanese encephalitis incidence by year, 1960–2013; Guangxi, China.4.12/100 000, 4.02/100 000, 3.88/100 000, and 3.81/100 000,
respectively. In addition, with a proportion of 14.28% of the
accumulated cases and a total incidence rate of 5.40/100 000,
Guigang City was considered to be the geographic area with the
most serious JE epidemic situation.
The 14 cities were sorted in descending order of JE incidence
rate for six different time-periods and the top ﬁve were ranked. In
the 1960s, the cities of Guigang, Beihai, Fangchenggang, Chongzuo,
and Yulin led the way with incidence rates of 19.60/100 000, 16.43/
100 000, 14.01/100 000, 10.17/100 000, and 9.56/100 000, respec-
tively. In the 1970s, the top ﬁve were Fangchenggang, Laibin,
Guilin, Guigang, and Beihai with rates of 11.98/100 000, 11.33/
100 000, 11.25/100 000, 10.89/100 000, and 10.31/100 000, re-
spectively. In the 1980s, the order was Yulin, Guigang, Fang-
chenggang, Laibin, and Hechi and their incidence rates were 3.36/
100 000, 3.28/100 000, 2.69/100 000, 2.01/100 000, and 1.75/
100 000, respectively. In the 1990s, Hezhou City, with an incidence
rate of 2.49/100 000, became the most seriously affected area,
followed by the cities of Hechi, Qinzhou, Yulin, and Baise with
incidence rates of 2.28/100 000, 1.87/100 000, 1.74/100 000, and
1.66/100 000, respectively. The highest incidence rate of 1.19/
100 000 was found for Hechi City in the 2000s and the other cities
in the top ﬁve were Baise (1.10/100 000), Hezhou (0.74/100 000),
Guigang (0.50/100 000), and Chongzuo (0.42/100 000). Finally,
from 2010 to 2013, the order was Hechi (0.34/100 000), Yulin
(0.17/100 000), Guigang (0.16/100 000), Laibin (0.14/100 000), and
Wuzhou (0.09/100 000).
3.2.3. Distribution of different population subgroups
Population distribution data were extracted from the NNDRS,
which provided the data since 2004. There were 1288 JE cases
reported between 2004 and 2013 in Guangxi, including 764 males
and 524 females (sex ratio 1.44:1.98). Sixty percent of the JE cases
were younger than 15 years old. Across all categories of profession,
housebound preschool children comprised the main JE population
(68.48%), followed by students (22.75%) and kindergarten children
(6.60%).
4. Discussion
4.1. Trends and characteristics of JE in Guangxi
Two epidemiological patterns of JE are recognized: epidemic
and endemic.8,9 Epidemic patterns are observed mainly in
northern areas, including P.R. China, Korea, and Vietnam.3 The
JE case reporting system has been mandated by law since 1951 in
P.R. China.10 Accumulated JE cases and average incidence rates for
Guangxi changed with a similar trend, increasing in the 1960s,
reaching a peak in the 1970s, and decreasing dramatically from the
1980s. However, its ranking increased. The JE incidence rate of
Guangxi ranked between 9th and 14th between 1990 and 2002 in
China, and rose to 5th in 2005.
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Guangxi, but the seasonal distribution across the whole country is
from June to October. The incidence reached a peak in July, which is
comparatively earlier than in the north of China.5,10–12 Between
1950 and 2013, few regional outbreaks were reported and most of
the cases were sporadic. Concentrations of cases in geographical
areas were associated with different decades, and most of them
were south of the Tropic of Cancer and located in eastern coastal
areas. The main JE population was children aged 0–14 years in
rural and suburban areas, especially housebound preschool
children. The reasons for this tendency and these characteristics
have already been mentioned.
4.2. Application of JE vaccine
Without the promotion of JE vaccine, the number of JE cases and
the incidence rate increased continuously during the 1960s and
1970s in Guangxi. The use of the MBD JE vaccine began in the late
1970s, and LAV-SA-14-14-2 was introduced in 1989.5 However,
few individuals received the vaccine because of its high price. Since
2008, JE immunization has been included in the national
immunization program, with LAV-SA-14-14-2 being used in
28 Chinese provinces, including Guangxi.12 Nevertheless, adult
JE cases and outbreaks have been reported.13 JE vaccine has been
provided free-of-charge to children aged 0–14 years, and the
number of cases and incidence rate were found to have decreased
dramatically from 2008 to 2013 (average 74 cases per year;
average incidence rate 0.16/100 000). However, according to
Pearson correlation analysis, the increased coverage with JE
vaccine did not reduce the incidence of JE (r = 0.595, p = 0.25)
(Table 2). Some research has indicated that approximately 55 000
(75%) JE cases occur in areas with well-established or developing
JE vaccination programs, while about 12 900 (19%) cases occur in
areas with minimal or no JE vaccination programs.14 It appears that
the linear relationship between coverage with the JE vaccine and
incidence is not consistent and the actual situation is more that
JE vaccine should be taken according to JE monitoring data.
4.3. Geographical and climatic features and industrial structure of
Guangxi
According to the latest report of the Intergovernmental Panel on
Climate Change (IPCC), the average warming of the global mean
surface temperature was 0.858 (range 0.65–1.068) over the period
from 1880 to 2012.15 With the warming of the global surface, theTable 2
Japanese encephalitis incidence and vaccine distribution by year, 2000–2013;
Guangxi, Chinaa
Year Consumption of
JE vaccine (10 000)
Incidence of
JE (100 000)
2000 242.50 0.03
2001 75.00 0.03
2002 342.51 0.05
2003 750.09 0.05
2004 418.48 0.04
2005 332.54 0.05
2006 261.03 0.01
2007 57.95 0.04
2008 25.77 0.01
2009 139.28 0.01
2010 145.60 0
2011 158.90 0
2012 156.38 0.01
2013 174.35 0
JE, Japanese encephalitis.
a Pearson analysis: r = 0.595, p = 0.025.greatest health risks will occur in populations that are most
affected by climate-sensitive diseases, such as vector-borne
diseases, and in those left behind by economic growth.16 JEV is
one of the vector-borne diseases and leads to major outbreaks in
tropical regions of Asia, along with China, Japan, Korea, and
countries of Southeast Asia.17
Guangxi is a coastal province situated in the south of P.R. China
and has a subtropical monsoon climate, with an annual mean
temperature of 16.0–23.0 8C. Most rain falls between April and
September and the annual average precipitation is 1070 mm.
These features provide suitable conditions for mosquitoes,
including Culex tritaeniorhynchus, to survive and breed. Another
factor is pig farming in Guangxi. As an underdeveloped area,
agriculture involving pig and poultry rearing is the principal
industry in Guangxi. In 2013, 34 567 000 live pigs were sold and
the number retained was 24 715 000. Many rural families have a
few free-range pigs and pigs are the hosts that spread JEV between
mosquitoes, pigs, and humans. In addition, large-scale commercial
poultry farming and family poultry rearing are common in
Guangxi, and young poultry may be amplifying hosts of impor-
tance in disease-endemic regions.18 The pathogen JEV, the
transmitter C. tritaeniorhynchus, the host pigs, and poultry
represent acute risks for JEV infection in humans, and they are
all found in Guangxi. In addition, bats play a role in the natural
cycle of JEV.19
4.4. Constituent ratios of susceptible population
The constituent ratio of children aged 0–14 years (the
susceptible JE population) has decreased each decade: 31.6%
during the 1990s, 26.19% during the 2000s, and 21.71% between
2010 and 2013. The average JE incidence rates in these three
decades were 1.34/100 000, 0.47/100 000, and 0.10/100 000,
respectively. Analyzing the constituent ratio and JE incidence rate
in the same decades via linear-by-linear association shows their
linear relationship to be signiﬁcant (Chi-square = 2691.44,
p = 0.00). This suggests that populations under the age of 15 years
are at higher risk of infection with JEV. Some animal experiments
have indicated the importance of age of infection on the magnitude
of viremia for JEV.18
4.5. Proposals on JE prevention based on epidemic features
JEV is the leading cause of vaccine-preventable encephalitis in
Asia and the Western Paciﬁc. There is no speciﬁc treatment for JE,
although ajwain oil has been found to have potential in vitro
antiviral activity against JEV.20 Avoiding being infected with JEV is
signiﬁcant for decreasing JE, because there is no speciﬁc drug or
treatment that can cure the disease.
On July 19, 2013, the Advisory Committee on Immunization
Practices (ACIP) voted to extend the existing recommendations for
the use of inactivated Vero cell culture-derived JE vaccine (Ixiaro;
Intercell Biomedical, Nanning, Guangxi, China) to include children
aged 2 months to 16 years.21 By age subgroup, the constituent ratio
of JE cases younger than 10 years was 91.53% between 2010 and
2013. Due to the climate in Guangxi, JE vaccine should be
administered during the period from March to April to the
population aged 2 months to 10 years old.
The eradication of mosquitoes would be another effective
measure. Monitoring the changes in climate and mosquito density,
and predicting JE tendency using the Gray model, would be useful.
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